John Giammona

Dr. John Giammona has more than twenty-five years of management, operations, business development, product sales, and technical consulting experience spanning the biopharma and life science industries.

In addition to his role as COO for Oscillo, John concurrently serves as VP of Biopharma Partnerships at Tasso Inc., a medical device company specializing in patient-centric blood collection technology. Previously, John was VP, Market Development & Medical Affairs for both Shield Therapeutics and Acasti Pharma, helping to launch a small molecule oral product with FDA approval at Shield.

John’s professional background includes the role of Chief Business Development Officer at AMR LLC, a multi-site clinical research company. In addition to his biopharma and site network corporate experience, he spent more than five years at one of the world’s largest CROs, PPD Inc., managing both sales and operations teams across the company. During his five years with Comprehensive Neuroscience, he was VP and General Manager of the CRO division.

John earned his doctorate from the University of Texas at Austin, College of Pharmacy (Pharmacology &Toxicology Division). He holds undergraduate and graduate engineering degrees from the Colorado School of Mines. He has served on two institutional review boards (IRBs).